RE:RE:RE:Q3Revenue growth flat. MD&A:
SUMMARY OF QUARTERLY RESULTS
The following table shows results from the last eight quarters:
Revenue Loss Loss per share
June 30, 2022 1,202,638 (1,047,290) (0.01)
March 31, 2022. 1,145,312 (606,917) (0.00)
December 31, 2021. 1,149,347 (919,901) (0.01)
September 30, 2021. 1,336,229 (1,945,027). (0.02)
June 30, 2021. 655,861. (1,339,732). (0.01)
March 31, 2021 130,515 (1,189,084) (0.01)
December 31, 2020 1,256,589 (911,510) (0.01)
September 30, 2020. 235,467. (2,268,924) (0.02)
There are no significant seasonal variations in quarterly results as the Company is not subject to significant seasonality in its commercial, research and corporate activities. While the quarterly results have ranged from a loss of approximately $911,000 to $2,269,000, the average loss equates to approximately $1,279,000. The Company expects a downward trend due to reducing research and costs associated with commissioning the extraction facility, while revenue from commercial activity increases.